Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Recent Patterns of Bladder Cancer Incidence and Mortality: A Global Overview Publisher



Mohammadian A1 ; Safari A2 ; Allah Bakeshei K3 ; Allah Bakeshei F4 ; Asti A5 ; Mohammadianhafshejani A6, 7 ; Salehiniya H8 ; Emamiyan M9 ; Khakpour H10
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Zabol University of Medical Sciences, Zabol, Iran
  3. 3. Department of Social Medicine, School of Public Health, Dezful University of Medical Sciences, Dezful, Iran
  4. 4. School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Behbahan Faculty of Medical Sciences, Behbahan, Iran
  6. 6. Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  7. 7. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
  9. 9. Shoushtar Faculty of Medical Science, Shoushtar, Iran
  10. 10. Iranshahr University of Medical Sciences, Iranshahr, Iran

Source: World Cancer Research Journal Published:2020


Abstract

Objective: Bladder cancer is the twelfth leading cancer and the fifteenth leading cancer-causing death worldwide. The present study was conducted to investigate recent patterns of bladder cancer incidence and mortality worldwide. Patients and Methods: In the present study, information on the incidence and mortality of bladder cancer in different regions of the world was extracted from the International Agency for Research on Cancer (IARC) (GLOBOCAN, 2018). We provided the Age-Standardized Incidence Rate (ASIR) and Age Standardized Mortality Rate (ASMR) of bladder cancer per 100,000 population. Results: During 2018, 549,393 new cases of bladder cancer were diagnosed worldwide, 125,311 (22.80%) of whom were female and 424,082 (77.19%) were male. In general, the global ASIR of bladder cancer was 5.7 (2.4 in women and 9.6 in men). There were also 199,922 deaths from bladder cancer, 51,652 (25.83%) of whom were female and 148,280 (74.16%) were male. The global ASMR of bladder cancer was 1.9 (0.87 in women and 3.2 in men). Conclusions: The highest ASIR of bladder cancer was observed in North America, in regions with very high Human Development Index (HDI) and in Europe. The highest mortality due to bladder cancer was observed in Europe, in regions with very high human development index and in EMRO. © 2020, Verduci International. All rights reserved.
Related Docs
View other Related Docs
1. Incidence and Mortality of Bladder Cancer and Their Relationship With Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
2. Preliminary Study of Prevalence for Bladder Cancer in Isfahan Province, Iran, Arab Journal of Urology (2018)
3. Investigation of Bladder Cancer Incidence in Isfahan, Iran, Tehran University Medical Journal (2019)
4. Cancers of Urinary System; Prevalence, Demographic, Jundishapur Journal of Chronic Disease Care (2019)
5. Significance of a Minor High-Grade Component in a Low-Grade Noninvasive Papillary Urothelial Carcinoma of Bladder, Human Pathology (2016)
6. Cancers of Urinary System, Prevalence, Demographic, Urologiia (2019)
7. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
8. Cancer Epidemiology and Trends in Sistan and Baluchestan Province, Iran, Medical Journal of the Islamic Republic of Iran (2015)
Experts (# of related papers)
View all Related Experts
Zahra Tolou-Ghamari (4)
Mohammad Reza Maracy (2)
Other Related Docs
9. The Incidence and Mortality of Prostate Cancer and Its Relationship With Development in Asia, Prostate International (2015)
10. National Surveillance of Cancer Survival in Iran (Irancansurv): Analysis of Data of 15 Cancer Sites From Nine Population-Based Cancer Registries, International Journal of Cancer (2022)
11. Cancer Incidence in Iran in 2014: Results of the Iranian National Population-Based Cancer Registry, Cancer Epidemiology (2019)
12. Performance of Novel Non-Invasive Urine Assay Uroseek in Cohorts of Equivocal Urine Cytology, Virchows Archiv (2020)
13. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran, Asian Pacific Journal of Cancer Prevention (2015)
14. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
15. How Much Is There a Correlation Between Clinical Symptoms and Urodynamic Findings of Overactive Bladder Patients?, Journal of Obstetrics, Gynecology and Cancer Research (2025)
16. Incidence, Prevalence, and Mortality Rate of Gastrointestinal Cancer in Isfahan, Iran: Application of the Miamod Method, Asian Pacific Journal of Cancer Prevention (2016)
17. Evaluation of the Effects of Prostate Radiation Therapy on Occludin Expression and Ultrasonography Characteristics of the Bladder, International Journal of Radiation Oncology Biology Physics (2017)
18. The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade, Clinical Genitourinary Cancer (2023)
19. Immunohistochemical Assessment of Basal and Luminal Markers in Non-Muscle Invasive Urothelial Carcinoma of Bladder, Virchows Archiv (2019)
20. Detection of Recurrent Bladder Cancer: Nmp22 Test or Urine Cytology?, Urology Journal (2012)
21. Vitamin E Reduces Superficial Bladder Cancer Recurrence: A Randomized Controlled Trial, International Journal of Preventive Medicine (2012)
22. An Unusual Presentation of Bladder Carcinoma in a Visceral Hernia: A Case Report and Literature Review, Cancer Reports (2025)
23. Epidemiology and Trend of Cancer in Isfahan 2005-2010, Journal of Research in Medical Sciences (2011)
24. The Evaluation of Tumor Recurrence Markers P53 and Cd44 in Low Risk Superficial Transitional Cell Carcinoma of the Bladder, Journal of Isfahan Medical School (2009)
25. Non-Invasive Detection of Urothelial Cancer Through the Analysis of Driver Gene Mutations and Aneuploidy, eLife (2018)
26. New Gleason Grade Groups; Epidemiologic Data From Isfahan, Iran Based on the New Classification, Immunopathologia Persa (2022)
27. International Epidemiology of Liver Cancer: Geographical Distribution, Secular Trends and Predicting the Future, Journal of Preventive Medicine and Hygiene (2020)
28. A Study of the Long-Term Trend of Epidemiological and Clinical Indices of Breast Cancer in Isfahan, Journal of Isfahan Medical School (2012)
29. Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015, International Journal of Preventive Medicine (2012)
30. Incidence and Distribution of Uroseek Gene Panel in a Multi-Institutional Cohort of Bladder Urothelial Carcinoma, Modern Pathology (2019)
31. Bladder Cancer in Iran: Geographical Distribution and Risk Factors, International Journal of Cancer Management (2017)